Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeekBreaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek
  • Home
  • Nation
  • Politics
  • Economy
  • Sports
  • Entertainment
  • International
  • Technology
  • Auto News
Reading: BPCL Outlook: Neutral – The Hindu BusinessLine
Share
Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeekBreaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek
  • Home
  • Nation
  • Politics
  • Economy
  • Sports
  • Entertainment
  • International
  • Technology
  • Auto News
© 2024 All Rights Reserved | Powered by India News Week
Trending Now: Stay updated with the latest breaking news from India and around the world
Broker’s call: BPCL (Neutral) - The Hindu BusinessLine
Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek > Economy > BPCL Outlook: Neutral – The Hindu BusinessLine
Economy

BPCL Outlook: Neutral – The Hindu BusinessLine

Economy Desk By Economy Desk March 7, 2025 2 Min Read
Share
SHARE

Target: ₹240

CMP: ₹261

A recent meeting with the management of Bharat Petroleum Corporation Ltd (BPCL) revealed some key insights. The proportion of Russian crude in the refining mix is expected to decrease to about 24 per cent by March 2025, down from the current 35-40 per cent. The company remains optimistic about positive developments in Mozambique in the near future, with gas supply set to commence in FY29. Additionally, BPCL is targeting an FY28 CGD EBITDA of ₹4,000 crore.

Although only ₹6,100 crore has been approved for the Andhra Pradesh refinery project, there is a possibility of incurring another ₹95,000 crore in capex. The ongoing ₹49,000 crore Bina refinery expansion is progressing, with the majority of spending scheduled for FY26/FY27.

Currently, BPCL is trading at a 1-year forward valuation of 1.3x P/B, in line with the mean -1 SD. It is now on par with HPCL on a 1-year forward P/B basis, compared to its historical premium of 50 per cent.

While the valuation seems reasonable and the company continues to deliver strong marketing performance, concerns linger over a subdued mid-term refining outlook. Our FY26E/FY27E PAT are 17/18 per cent sensitive to every $1/bbl change in GRM, and the commencement of a new capex cycle adds to these worries. Therefore, we reiterate our Neutral rating with an SoTP-based valuation of ₹240/share

SHARE

  • Copy link
  • Email
  • Facebook
  • Twitter
  • Telegram
  • LinkedIn
  • WhatsApp
  • Reddit

Published on March 7, 2025

TAGGED:Economy NewsNews
Share This Article
Twitter Copy Link
Previous Article Rupee appreciates 20 paise to close at 86.92 against US dollar Rupee gains 20 paise, ends at 86.92 against dollar
Next Article Why Canada should join the EU Embracing European Union Membership: A Strategic Move for Canada
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Latest News

Jessica Pegula Defeats Aryna Sabalenka 6-0 in Final Set at Berlin Open

June 21, 2026

Rajasthan NEET Aspirant Kulsum Bano Initially Denied Entry Over Burqa Policy

June 21, 2026

Mortgage Rates Drop to 6.47% in India, Boosting Homebuyer Confidence

June 21, 2026

Mumbai Elderly Shop Owner Faces Harassment Over Religious Identity Amid Rising Tensions

June 21, 2026
Open-market buyback set to surge as cash returns hit 3-year high

Cash Returns Reach Three-Year High, Triggering Surge in Open-Market Buybacks

June 21, 2026
WTC Updated Points table after Matt Henry's record outing powers New Zealand to Oval Test win

WTC Points Table Update: New Zealand Rises After Matt Henry’s Stellar Performance

June 21, 2026

You Might Also Like

Transformer stolen, UP village in dark for weeks
Nation

Stolen Transformer Leaves UP Village in Darkness for Weeks

2 Min Read
Rising gold imports in India: An explainer
Economy

Surge in India’s Gold Imports: Understanding the Growing Demand

6 Min Read
Vedanta demerger to add ₹84 per share in each business vertical
Economy

Vedanta’s Demerger Set to Boost Value by ₹84 Per Share Across Verticals

3 Min Read
Senores Pharmaceuticals IPO: Opens today at ₹372-391, should you apply?
Economy

Is Senores Pharmaceuticals IPO a Value Investment at ₹372-391?

2 Min Read

About IndiaNewsWeek

IndiaNewsWeek is your trusted source for breaking news, in-depth analysis, and comprehensive coverage of India and the world. We deliver accurate, timely reporting across politics, economy, sports, entertainment, and technology.

contact@indianewsweek.com

Quick Links

  • Nation
  • Politics
  • Economy
  • International
  • Sports
  • Entertainment

More Sections

  • Technology
  • Auto News
  • Education
  • About Us
  • Contact
  • Privacy Policy

Stay Connected

Follow us on social media for the latest updates and breaking news.

Facebook
X (Twitter)
YouTube
Follow US
© 2026 IndiaNewsWeek. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?